RxDoctor Payments Data

Loren Garza

Adult Health · Louisville, KYNPI 1346850294

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 343 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 32.4% of the total. Among adult health clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,734in general payments, 2019–2025

Across 343 payments — averaging $16.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Johnson & Johnson$461
  • Takeda Pharmaceuticals U.S.A., Inc.$243
  • Sanofi$172
  • Nestle Healthcare Nutrition Inc.$158
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$5,54797%
  • Education$1863%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,734 in reported general payments places this provider in the 90th percentile of 170 adult health providers in Kentucky.

See all adult health providers in Kentucky

Medicare billing

Part B allowed, 2024
$40,114
Medicare patients
235
Services billed
416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase49$180,059
LinzessLinaclotide26$30,527
MovantikNaloxegol Oxalate25$12,314
Dexlansoprazole DrDexlansoprazole21$4,905
Mesalamine15$3,913
Sucralfate20$3,733
Ursodiol14$2,946
Pantoprazole Sodium183$2,517
Esomeprazole Magnesium89$1,486
Omeprazole116$1,285
Ondansetron OdtOndansetron38$861
Dicyclomine Hcl58$637
Famotidine77$572
Metoclopramide Hcl66$423
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine12$327

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,858$210,58675 claims
Redhill Biopharma Inc.Movantik$15$12,31425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 170 adult health providers in Kentucky.

Other adult health in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →